Press

Ophthalmology Times Cutting-Edge Advancements Avisi Technologies FDA, IDE

Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA

Key Takeaways VisiPlate’s IDE approval allows clinical studies in the US, focusing on safety and effectiveness data collection for the novel glaucoma treatment device. The device’s unique metamaterial and multichannel design aim to reduce IOP and minimize blockage risks, offering potential advantages over current surgical treatments. VITA trial results demonstrated a 40.4% mean IOP reduction […]

Avisi Technologies Receives FDA Approval to Study Novel Approach to Glaucoma Treatment

Avisi Receives FDA Approval to Study Novel Approach to Glaucoma Treatment

• Approved SAPPHIRE trial is a prospective, multicenter, open-label clinical trial with 1-year follow up, evaluating safety and effectiveness of VisiPlate® aqueous shunt in glaucoma patients. • VisiPlate® shunt is uniquely designed: novel metamaterial, thinner than a human hair, aiming for longevity, comfort, and aesthetics. • The multiple, redundant microchannels provide sustained aqueous flow while […]

Avisi Technologies Presents Positive Six-Month Clinical Data for VisiPlate® Aqueous Shunt at the American Glaucoma Society

REDWOOD CITY, Calif., April 2, 2025 /PRNewswire/ — Avisi Technologies, a clinical-stage ophthalmic device company, today announced encouraging six‐month interim results from the VITA trial evaluating its VisiPlate® device, an ultrathin, multichannel aqueous shunt in study subjects diagnosed with open-angle glaucoma. Data were presented by Eydie Miller-Ellis, MD, as a Top Paper at the American […]

Avisi Technologies Thought Leadership Impact at LSI US ’25

Recap of Avisi CEO’s Participation in Two Impactful Panels at LSI Emerging Medtech Summit Avisi Technologies returns to the Life Science Intelligence (LSI) stage with CEO Rui Jing Jiang participating in several panel discussions at the 2025 MedTech Summit. The panel discussions involved leadership and design strategies for achieving success within the MedTech industry. Life […]

Ultrathin Shunt Shows Promising Results in Trial

In an article by Glaucoma Physician, Jim Gallagher reports on the positive six-month results for VisiPlate® from the VITA trial presented by Dr. Eydie Miller-Ellis at the American Glaucoma Society (AGS). This was considered a top paper by the society and presented during the Surgery Day Paper Presentation at AGS. Dr. Miller-Ellis serves as the […]

Next-Gen Avisi Technologies Aims for “One and Done” in a MIGS Device

Some medtech start-ups begin with an inventor with a novel idea; others seek out an unmet clinical need looking for a solution. Avisi Technologies began with market research, that is, a direct appeal to glaucoma specialists to determine what they were missing in their tool kits, and specifically, how the current generation of devices for minimally invasive […]